Submitted by Anonymous (not verified) on 7 October 2026 - 13:42
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 11, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 11, Status: Authorised